Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?
Y Jiang, Y Jiang, M Li, Q Yu - Frontiers in Pharmacology, 2023 - frontiersin.org
Cancer is one of the leading causes of death worldwide, and with the continuous
development of life sciences and pharmaceutical technology, more and more antitumor …
development of life sciences and pharmaceutical technology, more and more antitumor …
DOPE/CHEMS-based EGFR-targeted immunoliposomes for docetaxel delivery: formulation development, physicochemical characterization and biological evaluation …
TS Moreira, ADO Silva, BRF Vasconcelos, ES Santos… - Pharmaceutics, 2023 - mdpi.com
Docetaxel (DTX) is a non-selective antineoplastic agent with low solubility and a series of
side effects. The technology of pH-sensitive and anti-epidermal growth factor receptor (anti …
side effects. The technology of pH-sensitive and anti-epidermal growth factor receptor (anti …
Utilizing fab fragment‐conjugated surface plasmon resonance‐based biosensor for detection of Salmonella Enteritidis
Although antibodies, a key element of biorecognition, are frequently used as biosensor
probes, the use of these large molecules can lead to adverse effects. Fab fragments can be …
probes, the use of these large molecules can lead to adverse effects. Fab fragments can be …